134 related articles for article (PubMed ID: 9580110)
1. Human apolipoprotein A-II is a pro-atherogenic molecule when it is expressed in transgenic mice at a level similar to that in humans: evidence of a potentially relevant species-specific interaction with diet.
Escolà-Gil JC; Marzal-Casacuberta A; Julve-Gil J; Ishida BY; Ordóñez-Llanos J; Chan L; González-Sastre F; Blanco-Vaca F
J Lipid Res; 1998 Feb; 39(2):457-62. PubMed ID: 9580110
[TBL] [Abstract][Full Text] [Related]
2. Decreased susceptibility to diet-induced atherosclerosis in human apolipoprotein A-II transgenic mice.
Tailleux A; Bouly M; Luc G; Castro G; Caillaud JM; Hennuyer N; Poulain P; Fruchart JC; Duverger N; Fiévet C
Arterioscler Thromb Vasc Biol; 2000 Nov; 20(11):2453-8. PubMed ID: 11073852
[TBL] [Abstract][Full Text] [Related]
3. Functional lecithin:cholesterol acyltransferase deficiency and high density lipoprotein deficiency in transgenic mice overexpressing human apolipoprotein A-II.
Marzal-Casacuberta A; Blanco-Vaca F; Ishida BY; Julve-Gil J; Shen J; Calvet-Márquez S; González-Sastre F; Chan L
J Biol Chem; 1996 Mar; 271(12):6720-8. PubMed ID: 8636092
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of human apolipoprotein A-II in transgenic mice does not impair macrophage-specific reverse cholesterol transport in vivo.
Rotllan N; Ribas V; Calpe-Berdiel L; Martín-Campos JM; Blanco-Vaca F; Escolà-Gil JC
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):e128-32. PubMed ID: 15994442
[TBL] [Abstract][Full Text] [Related]
5. In vivo interactions of apoA-II, apoA-I, and hepatic lipase contributing to HDL structure and antiatherogenic functions.
Hedrick CC; Castellani LW; Wong H; Lusis AJ
J Lipid Res; 2001 Apr; 42(4):563-70. PubMed ID: 11290828
[TBL] [Abstract][Full Text] [Related]
6. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
[TBL] [Abstract][Full Text] [Related]
7. ApoA-II expression in CETP transgenic mice increases VLDL production and impairs VLDL clearance.
Escolà-Gil JC; Julve J; Marzal-Casacuberta A; Ordóñez-Llanos J; González-Sastre F; Blanco-Vaca F
J Lipid Res; 2001 Feb; 42(2):241-8. PubMed ID: 11181754
[TBL] [Abstract][Full Text] [Related]
8. Expression of human lecithin-cholesterol acyltransferase in transgenic mice. Effect of human apolipoprotein AI and human apolipoprotein all on plasma lipoprotein cholesterol metabolism.
Francone OL; Gong EL; Ng DS; Fielding CJ; Rubin EM
J Clin Invest; 1995 Sep; 96(3):1440-8. PubMed ID: 7657816
[TBL] [Abstract][Full Text] [Related]
9. High density lipoprotein particle size restriction in apolipoprotein A-I(Milano) transgenic mice.
Bielicki JK; Forte TM; McCall MR; Stoltzfus LJ; Chiesa G; Sirtori CR; Franceschini G; Rubin EM
J Lipid Res; 1997 Nov; 38(11):2314-21. PubMed ID: 9392429
[TBL] [Abstract][Full Text] [Related]
10. Transgenic mice expressing high levels of human apolipoprotein B develop severe atherosclerotic lesions in response to a high-fat diet.
Purcell-Huynh DA; Farese RV; Johnson DF; Flynn LM; Pierotti V; Newland DL; Linton MF; Sanan DA; Young SG
J Clin Invest; 1995 May; 95(5):2246-57. PubMed ID: 7738190
[TBL] [Abstract][Full Text] [Related]
11. Atherosclerosis in transgenic mice overexpressing apolipoprotein A-II.
Warden CH; Hedrick CC; Qiao JH; Castellani LW; Lusis AJ
Science; 1993 Jul; 261(5120):469-72. PubMed ID: 8332912
[TBL] [Abstract][Full Text] [Related]
12. Reduced aortic lesions and elevated high density lipoprotein levels in transgenic mice overexpressing mouse apolipoprotein A-IV.
Cohen RD; Castellani LW; Qiao JH; Van Lenten BJ; Lusis AJ; Reue K
J Clin Invest; 1997 Apr; 99(8):1906-16. PubMed ID: 9109435
[TBL] [Abstract][Full Text] [Related]
13. Protein composition determines the anti-atherogenic properties of HDL in transgenic mice.
Schultz JR; Verstuyft JG; Gong EL; Nichols AV; Rubin EM
Nature; 1993 Oct; 365(6448):762-4. PubMed ID: 8413656
[TBL] [Abstract][Full Text] [Related]
14. Free cholesterol deposition in the cornea of human apolipoprotein A-II transgenic mice with functional lecithin: cholesterol acyltransferase deficiency.
Julve-Gil J; Ruiz-Pérez E; Casaroli-Marano RP; Marzal-Casacuberta A; Escolà-Gil JC; González-Sastre F; Blanco-Vaca F
Metabolism; 1999 Apr; 48(4):415-21. PubMed ID: 10206431
[TBL] [Abstract][Full Text] [Related]
15. Transgenic overexpression of human lecithin: cholesterol acyltransferase (LCAT) in mice does not increase aortic cholesterol deposition.
Furbee JW; Parks JS
Atherosclerosis; 2002 Nov; 165(1):89-100. PubMed ID: 12208474
[TBL] [Abstract][Full Text] [Related]
16. Human ApoA-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic mice.
Zhong S; Goldberg IJ; Bruce C; Rubin E; Breslow JL; Tall A
J Clin Invest; 1994 Dec; 94(6):2457-67. PubMed ID: 7989603
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein A-II, HDL metabolism and atherosclerosis.
Tailleux A; Duriez P; Fruchart JC; Clavey V
Atherosclerosis; 2002 Sep; 164(1):1-13. PubMed ID: 12119188
[TBL] [Abstract][Full Text] [Related]
18. ApoA-I deficiency causes both hypertriglyceridemia and increased atherosclerosis in human apoB transgenic mice.
Voyiaziakis E; Goldberg IJ; Plump AS; Rubin EM; Breslow JL; Huang LS
J Lipid Res; 1998 Feb; 39(2):313-21. PubMed ID: 9507992
[TBL] [Abstract][Full Text] [Related]
19. Short-term feeding of atherogenic diet to mice results in reduction of HDL and paraoxonase that may be mediated by an immune mechanism.
Hedrick CC; Hassan K; Hough GP; Yoo JH; Simzar S; Quinto CR; Kim SM; Dooley A; Langi S; Hama SY; Navab M; Witztum JL; Fogelman AM
Arterioscler Thromb Vasc Biol; 2000 Aug; 20(8):1946-52. PubMed ID: 10938016
[TBL] [Abstract][Full Text] [Related]
20. Human apolipoprotein A-I prevents atherosclerosis associated with apolipoprotein[a] in transgenic mice.
Liu AC; Lawn RM; Verstuyft JG; Rubin EM
J Lipid Res; 1994 Dec; 35(12):2263-7. PubMed ID: 7897323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
